Diarrhea News and Research

Latest Diarrhea News and Research

FDA grants accelerated approval for Sprycel (dasatinib)

FDA grants accelerated approval for Sprycel (dasatinib), a new oral treatment for patients with chronic myeloid leukemia (CML),

29 Jun 2006

Structure of bacteriophage shown to resemble a human virus

New research has revealed that the structure of a bacteriophage, a virus infecting bacteria, resembles that of certain dangerous viruses that infect people.

26 Jun 2006

FDA approves Prezista (darunavir)

FDA approves Prezista (darunavir), a new drug for adults whose infection with the human immunodeficiency virus (HIV) has not responded to treatment with other antiretroviral drugs.

26 Jun 2006

Cadbury kept quiet about contaminated chocolate

Chocolate manufacturer Cadbury Schweppes has been forced to recall thousands of chocolate bars because of claims they are contaminated by salmonella.

26 Jun 2006

Colonel Sanders goes to court

The fast food chain Kentucky Fried Chicken (KFC) is about to be sued over it's cooking methods.

20 Jun 2006

Microbes could represent the future of medicine

Not all bacteria are bad. In fact, beneficial microbes could represent the future of medicine, with the potential to treat a variety of diseases in humans and animals from diarrhea and eczema to gum disease and autoimmune disorders.

9 Jun 2006

New football boots and toxic shock syndrome

As the World Cup kicks off, doctors in this week's British Medical Journal report an unusual condition that can develop in budding young footballers.

8 Jun 2006

Sunitinib shows promise in treating metastatic renal cell cancer

A new study suggests that sunitinib is a promising agent for treatment of metastatic renal cell cancer, currently a disease without highly effective treatment options, according to an article in the June 7 issue of the Journal of the American Medical Association.

7 Jun 2006

Long-term benefits of imatinib for patients newly diagnosed with chronic myelogenous leukemia

The overall survival of most people with chronic myelogenous leukemia (CML) treated with imatinib (Gleevec, STI-571) is extremely high and the relapse rate is quite low, according to new data from a study out of the Oregon Health & Science University Cancer Institute.

6 Jun 2006

Angola reports 41,475 cholera cases and 1576 deaths

As of 31 May 2006, Angola has reported a total of 41,475 cholera cases and 1576 deaths (overall case fatality rate (CFR) 3.8%).

6 Jun 2006

Polio outbreak a setback for Namibia

Health officials in Namibia say initial tests indicate the country is experiencing an outbreak of polio.

6 Jun 2006

Hydrophobic statins not associated with increased breast cancer risk

A report published in the Journal of the National Cancer Institute found that women who took statins--the widely used cholesterol lowering drugs--do not face an increased breast cancer risk as had been suggested by some previous studies.

6 Jun 2006

Shortages of specific medicines and supplies in Indonesia

The emergency continues in Indonesia, as World Health Organization (WHO) works with authorities work to provide medical care to survivors, to acquire the right kinds of medicines and equipment.

1 Jun 2006

Cognitive behavioral therapy effective in treating irritable bowel syndrome

According to the latest research behavioral therapy was more effective in treating the symptoms of irritable bowel syndrome (IBS) than being on a waiting list for treatment.

29 May 2006

Arthritis drug wins approval for use in children with Crohn's disease

The Food and Drug Administration in the U.S. has given approval for the drug Remicade for use in children with active Crohn's disease(CD), a chronic and debilitating condition.

21 May 2006

Using probiotics is a safe and effective way to prevent asthma in children

In the first effort of its kind in the United States, researchers at the University of California, San Francisco have launched a study to determine whether giving active probiotic supplements to infants can delay or prevent asthma in children.

17 May 2006

Fifty more deaths in Angola from cholera

According to the World Health Organization (WHO) another 50 people have died from cholera in Angola in the last week.

14 May 2006

Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax

Anthrax vaccine administered in combination with a short course of antibiotics completely protected nonhuman primates from inhalational anthrax, the most lethal form of the disease, according to scientists at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID).

3 May 2006

New drug may revolutionize how chronic iron overload is treated in chronic anemia patients

Those with severe chronic anemias need frequent blood transfusions to remain healthy, but such frequent transfusions can cause a potentially deadly buildup of iron in the body, leading to heart and liver failure. The traditional treatment to remove excess iron is so onerous that many patients choose to forgo it, putting their own lives at risk. The results of an international study on deferasirox, a new drug that may revolutionize the way chronic iron overload is treated, will be published in the May 1, 2006, issue of Blood, the official journal of the American Society of Hematology.

26 Apr 2006

Australian scientists tackle deadly Q fever

Scientists at James Cook University have taken the lead in developing a new vaccine against a highly infectious cattleyard disease caused by a bacteria which has the potential to be developed as a bioterrorist weapon.

20 Apr 2006